1 - 25 of 43 results for author:"Kogan S." in Literature citations
Results Customize
› Repeat search in UniProtKB (6)
| Life stress, the dopamine receptor gene, and emerging adult drug use trajectories: a longitudinal, multilevel, mediated moderation analysis. Brody G.H., Chen Y.F., Yu T., Beach S.R., Kogan S.M., Simons R.L., Windle M., Philibert R.A. Dev. Psychopathol. 24:941-951(2012) · Mapped (56) |
| An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model. Bergerson R.J., Collier L.S., Sarver A.L., Been R.A., Lugthart S., Diers M.D., Zuber J., Rappaport A.R., Nixon M.J., Silverstein K.A. et al. Blood 119:4512-4523(2012) · Mapped (12) |
| Control of the senescence-associated secretory phenotype by NF-kappaB promotes senescence and enhances chemosensitivity. Chien Y., Scuoppo C., Wang X., Fang X., Balgley B., Bolden J.E., Premsrirut P., Luo W., Chicas A., Lee C.S. et al. Genes Dev. 25:2125-2136(2011) · Mapped (3) |
| An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Zuber J., Rappaport A.R., Luo W., Wang E., Chen C., Vaseva A.V., Shi J., Weissmueller S., Fellmann C., Fellman C. et al. Genes Dev. 25:1628-1640(2011) · Mapped (10) |
| RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Zuber J., Shi J., Wang E., Rappaport A.R., Herrmann H., Sison E.A., Magoon D., Qi J., Blatt K., Wunderlich M. et al. Nature 478:524-528(2011) · Mapped (9) |
| PML-RARalpha enhances constitutive autophagic activity through inhibiting the Akt/mTOR pathway. Huang Y., Hou J.K., Chen T.T., Zhao X.Y., Yan Z.W., Zhang J., Yang J., Kogan S.C., Chen G.Q. Autophagy 7:1132-1144(2011) · Mapped (20) |
| A rapid and scalable system for studying gene function in mice using conditional RNA interference. Premsrirut P.K., Dow L.E., Kim S.Y., Camiolo M., Malone C.D., Miething C., Scuoppo C., Zuber J., Dickins R.A., Kogan S.C. et al. Cell 145:145-158(2011) · Mapped (39) |
| Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice. Nakamura J.L., Phong C., Pinarbasi E., Kogan S.C., Vandenberg S., Horvai A.E., Faddegon B.A., Fiedler D., Shokat K., Houseman B.T. et al. Cancer Res. 71:106-115(2011) · Mapped (5) |
| Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus. Li Q., Haigis K.M., McDaniel A., Harding-Theobald E., Kogan S.C., Akagi K., Wong J.C., Braun B.S., Wolff L., Jacks T. et al. Blood 117:2022-2032(2011) · Mapped (6) |
| Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. Jones L., Wei G., Sevcikova S., Phan V., Jain S., Shieh A., Wong J.C., Li M., Dubansky J., Maunakea M.L. et al. J. Exp. Med. 207:2581-2594(2010) · Mapped (13) |
| PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia. Subramanyam D., Belair C.D., Barry-Holson K.Q., Lin H., Kogan S.C., Passegue E., Blelloch R. Cancer Res. 70:8792-8801(2010) · Mapped (3) |
| 5-HTTLPR status moderates the effect of early adolescent substance use on risky sexual behavior. Kogan S.M., Beach S.R., Philibert R.A., Brody G.H., Chen Y.F., Lei M.K. Health Psychol 29:471-476(2010) · Mapped (3) |
| p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal. Zhao Z., Zuber J., Diaz-Flores E., Lintault L., Kogan S.C., Shannon K., Lowe S.W. Genes Dev. 24:1389-1402(2010) · Mapped (24) |
| Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies. Wong J.C., Zhang Y., Lieuw K.H., Tran M.T., Forgo E., Weinfurtner K., Alzamora P., Kogan S.C., Akagi K., Wolff L. et al. Blood 115:4524-4532(2010) · Mapped (21) |
| Mutant Ikzf1, KrasG12D, and Notch1 cooperate in T lineage leukemogenesis and modulate responses to targeted agents. Dail M., Li Q., McDaniel A., Wong J., Akagi K., Huang B., Kang H.C., Kogan S.C., Shokat K., Wolff L. et al. Proc. Natl. Acad. Sci. U.S.A. 107:5106-5111(2010) · Mapped (18) |
| Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras. Lauchle J.O., Kim D., Le D.T., Akagi K., Crone M., Krisman K., Warner K., Bonifas J.M., Li Q., Coakley K.M. et al. Nature 461:411-414(2009) · Mapped (5) |
| Participation in a family-centered prevention program decreases genetic risk for adolescents' risky behaviors. Brody G.H., Chen Y.F., Beach S.R., Philibert R.A., Kogan S.M. Pediatrics 124:911-917(2009) · Mapped (3) |
| Change in caregiver depression in response to parent training: genetic moderation of intervention effects. Beach S.R., Brody G.H., Kogan S.M., Philibert R.A., Chen Y.F., Lei M.K. J Fam Psychol 23:112-117(2009) · Mapped (3) |
| Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Viatour P., Somervaille T.C., Venkatasubrahmanyam S., Kogan S., McLaughlin M.E., Weissman I.L., Butte A.J., Passegue E., Sage J. Cell Stem Cell 3:416-428(2008) · Mapped (16) |
| mTORC1 promotes survival through translational control of Mcl-1. Mills J.R., Hippo Y., Robert F., Chen S.M., Malina A., Lin C.J., Trojahn U., Wendel H.G., Charest A., Bronson R.T. et al. Proc. Natl. Acad. Sci. U.S.A. 105:10853-10858(2008) · Mapped (4) |
| Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposure. Nagasubramanian R., Hansen R.J., Delaney S.M., Cherian M.M., Samson L.D., Kogan S.C., Dolan M.E. Mutagenesis 23:341-346(2008) · Mapped (7) |
| The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with beta-blockade. Kelley-Hedgepeth A., Peter I., Kip K., Montefusco M., Kogan S., Cox D., Ordovas J., Levy D., Reis S., Mendelsohn M. et al. J Hum Hypertens 22:512-515(2008) · Mapped (1) |
| Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Joslin J.M., Fernald A.A., Tennant T.R., Davis E.M., Kogan S.C., Anastasi J., Crispino J.D., Le Beau M.M. Blood 110:719-726(2007) · Mapped (13) |
| Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice. Kim A., Morgan K., Hasz D.E., Wiesner S.M., Lauchle J.O., Geurts J.L., Diers M.D., Le D.T., Kogan S.C., Parada L.F. et al. Blood 109:1687-1691(2007) · Mapped (14) |
| Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo. Wendel H.G., Malina A., Zhao Z., Zender L., Kogan S.C., Cordon-Cardo C., Pelletier J., Lowe S.W. Cancer Res. 66:7639-7646(2006) · Mapped (19) |